Financial News
New Crypto Pepeto Passes $8.25M While Dogecoin Price Prediction Heats Up and Elon Musk Confirms X Money Goes Live in April
Dubai, UAE, March 21, 2026 (GLOBE NEWSWIRE) -- Pepeto just cleared $8.25 million in presale and every signal around this new crypto is lining up in a way the market has witnessed only twice, once with Dogecoin and once with Shiba Inu, both just before Elon Musk turned them into global headlines.
All
Basic Materials
Communication Services
Consumer Cyclical
Consumer Defensive
Energy
Financial Services
Healthcare
Industrials
Real Estate
Technology
Utilities
Macro
All Sentiment
Bullish
Neutral
Bearish
1,013 articles
CIBC Private Wealth Group LLC Reduces Stock Holdings in CVS Health Corporation $CVS
CIBC Private Wealth Group LLC cut its position in shares of CVS Health Corporation (NYSE:CVS – Free Report) by 17.4% during the third quarter,...
CIBC Private Wealth Group LLC Reduces Stock Holdings in CVS Health Corporation $CVS
CIBC Private Wealth Group LLC cut its position in shares of CVS Health Corporation (NYSE:CVS – Free Report) by 17.4% during the third quarter,...
Groupama Asset Managment Sells 4,255 Shares of AptarGroup, Inc. $ATR
Groupama Asset Managment reduced its position in shares of AptarGroup, Inc. (NYSE:ATR – Free Report) by 70.4% in the third quarter, according...
Centene Corporation $CNC Shares Sold by Groupama Asset Managment
Groupama Asset Managment reduced its stake in Centene Corporation (NYSE:CNC – Free Report) by 70.5% during the 3rd quarter, according to the...
Centene Corporation $CNC Shares Sold by Groupama Asset Managment
Groupama Asset Managment reduced its stake in Centene Corporation (NYSE:CNC – Free Report) by 70.5% during the 3rd quarter, according to the...
Groupama Asset Managment Lowers Position in Jazz Pharmaceuticals PLC $JAZZ
Groupama Asset Managment decreased its holdings in shares of Jazz Pharmaceuticals PLC (NASDAQ:JAZZ – Free Report) by 70.5% in the 3rd quarter,...
Valneva (NASDAQ:VALN) Shares Gap Down – Here’s Why
Valneva SE Sponsored ADR (NASDAQ:VALN – Get Free Report) shares gapped down before the market opened on Friday . The stock had previously...
Ambu A/S (OTCMKTS:AMBBY) Shares Gap Down – What’s Next?
Ambu A/S Unsponsored ADR (OTCMKTS:AMBBY – Get Free Report) gapped down before the market opened on Friday . The stock had previously closed at...
Nanobiotix (NASDAQ:NBTX) Shares Gap Down – Here’s What Happened
Nanobiotix S.A. – Sponsored ADR (NASDAQ:NBTX – Get Free Report)’s share price gapped down before the market opened on Friday . The...
Eli Lilly and Company $LLY Stock Position Lessened by Abner Herrman & Brock LLC
Abner Herrman & Brock LLC trimmed its holdings in Eli Lilly and Company (NYSE:LLY – Free Report) by 3.7% during the fourth quarter,...
Eli Lilly and Company $LLY Stock Position Lessened by Abner Herrman & Brock LLC
Abner Herrman & Brock LLC trimmed its holdings in Eli Lilly and Company (NYSE:LLY – Free Report) by 3.7% during the fourth quarter,...
WELL Health Technologies (TSE:WELL) Stock Price Down 7.4% – What’s Next?
WELL Health Technologies Corp. (TSE:WELL – Get Free Report) shares traded down 7.4% during trading on Friday . The stock traded as low as...
Merit Medical Systems (NASDAQ:MMSI) Hits New 52-Week Low – Should You Sell?
Merit Medical Systems, Inc. (NASDAQ:MMSI – Get Free Report)’s share price reached a new 52-week low during trading on Friday . The stock...
Qiagen (NYSE:QGEN) Sets New 12-Month Low – Should You Sell?
Qiagen N.V. (NYSE:QGEN – Get Free Report) hit a new 52-week low during trading on Friday . The company traded as low as $39.85 and last traded...
SkinBioTherapeutics (LON:SBTX) Trading Down 34.6% – What’s Next?
SkinBioTherapeutics plc (LON:SBTX – Get Free Report) fell 34.6% on Friday . The stock traded as low as GBX 6.25 and last traded at GBX 6.28....
Scancell (LON:SCLP) Shares Down 3.1% – Here’s What Happened
Scancell Holdings plc (LON:SCLP – Get Free Report)’s stock price fell 3.1% on Friday . The company traded as low as GBX 11.63 and last...
Humana (NYSE:HUM) Reaches New 52-Week Low – Here’s What Happened
Humana Inc. (NYSE:HUM – Get Free Report) reached a new 52-week low during mid-day trading on Friday . The company traded as low as $163.11 and...
Mark Cuban Says AI Revolution Is Easier For White Collar Workers Than PC Revolution, Predicts Job Cuts At Big Companies
Billionaire entrepreneur Mark Cuban took to X to weigh in on the ongoing AI revolution and its potential effects on the workforce.
AI Mirrors PC...
📰
Maze Therapeutics President Sells All Insider Shares as Q4 Earning Report Nears
This pharmaceutical company's executive sold all his direct shares less than a month before a highly anticipated earnings report.
📰
This Fund Just Cut a Viridian Stock Position by Over $80 Million. Here's What Investors Should Know
This clinical-stage biotech develops antibody therapies for thyroid eye disease, advancing multiple candidates through its R&D pipeline.
📰
This Biotech Stock Up 135% Just Faced a $44 Million Trim. Here's What Investors Should Know
This clinical-stage biotech develops bladder-sparing therapies for high-risk cancer patients, targeting unmet needs in oncology treatment.
📰
DAFNA Capital Trims iShares Biotechnology ETF Within Broader Biotech Portfolio, According to Recent SEC Filing
iShares Biotechnology ETF (IBB) gives investors biotech exposure through large, established drug developers rather than smaller speculative names....
📰
DAFNA Capital Trims iShares Biotechnology ETF Within Broader Biotech Portfolio, According to Recent SEC Filing
iShares Biotechnology ETF (IBB) gives investors biotech exposure through large, established drug developers rather than smaller speculative names....
📰
DAFNA Capital Trims iShares Biotechnology ETF Within Broader Biotech Portfolio, According to Recent SEC Filing
iShares Biotechnology ETF (IBB) gives investors biotech exposure through large, established drug developers rather than smaller speculative names....
📰
DAFNA Capital Trims iShares Biotechnology ETF Within Broader Biotech Portfolio, According to Recent SEC Filing
iShares Biotechnology ETF (IBB) gives investors biotech exposure through large, established drug developers rather than smaller speculative names....
📰
2 Beaten-Down Stocks That Still Aren't Worth Buying
These stocks aren't nearly as cheap as they look.
📰
2 Beaten-Down Stocks That Still Aren't Worth Buying
These stocks aren't nearly as cheap as they look.
📰
ENAVATE's Zenas Bio Pharma add Is a Footnote — The Obexelimab Pipeline Is What to Watch
This clinical-stage biotech develops immunology therapies for autoimmune and inflammatory diseases, with a diverse pipeline underway.
📰
TRUBRIDGE ALERT: Bragar Eagel & Squire, P.C. is Investigating TruBridge, Inc. on Behalf of TruBridge Stockholders and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In TruBridge (TBRG)To Contact Him Directly...
📰
IRON Investor News: If You Have Suffered Losses in Disc Medicine, Inc. (NASDAQ: IRON), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" />
<p...
📰
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages PomDoctor Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - POM
NEW YORK, March 21, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of PomDoctor...
📰
RARE DEADLINE NOTICE: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Ultragenyx Pharmaceutical Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - RARE
NEW YORK, March 21, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of...
Anderson Hoagland & Co. Has $22.12 Million Position in Eli Lilly and Company $LLY
Anderson Hoagland & Co. trimmed its stake in Eli Lilly and Company (NYSE:LLY – Free Report) by 8.9% in the fourth quarter, according to...
Coastline Trust Co Sells 4,558 Shares of Zoetis Inc. $ZTS
Coastline Trust Co trimmed its stake in shares of Zoetis Inc. (NYSE:ZTS – Free Report) by 86.0% in the 4th quarter, according to its most...
Coastline Trust Co Sells 4,558 Shares of Zoetis Inc. $ZTS
Coastline Trust Co trimmed its stake in shares of Zoetis Inc. (NYSE:ZTS – Free Report) by 86.0% in the 4th quarter, according to its most...
Haemonetics Corporation $HAE Shares Sold by Confluence Investment Management LLC
Confluence Investment Management LLC trimmed its holdings in shares of Haemonetics Corporation (NYSE:HAE – Free Report) by 23.2% during the...
Pliant Therapeutics, Inc. (NASDAQ:PLRX) Given Consensus Recommendation of “Reduce” by Brokerages
Shares of Pliant Therapeutics, Inc. (NASDAQ:PLRX – Get Free Report) have earned an average rating of “Reduce” from the five...
Supernus Pharmaceuticals (NASDAQ:SUPN) VP Sells $2,514,000.00 in Stock
Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN – Get Free Report) VP Padmanabh Bhatt sold 50,000 shares of the firm’s stock in a transaction...
Insider Selling: BiomX (NYSEAMERICAN:PHGE) Director Sells $2,650,000.00 in Stock
BiomX Inc. (NYSEAMERICAN:PHGE – Get Free Report) Director Reuven Yeganeh sold 530,000 shares of the firm’s stock in a transaction dated...
John Kao Sells 73,046 Shares of Alignment Healthcare (NASDAQ:ALHC) Stock
Alignment Healthcare, Inc. (NASDAQ:ALHC – Get Free Report) CEO John Kao sold 73,046 shares of Alignment Healthcare stock in a transaction that...
Centessa Pharmaceuticals (NASDAQ:CNTA) Insider Sells $1,827,105.28 in Stock
Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA – Get Free Report) insider Karen Anderson sold 64,768 shares of the business’s...
Cytokinetics (NASDAQ:CYTK) CEO Sells $2,274,752.15 in Stock
Cytokinetics, Incorporated (NASDAQ:CYTK – Get Free Report) CEO Robert Blum sold 36,601 shares of the company’s stock in a transaction on...
Pablo Cagnoni Sells 18,667 Shares of Incyte (NASDAQ:INCY) Stock
Incyte Corporation (NASDAQ:INCY – Get Free Report) insider Pablo Cagnoni sold 18,667 shares of the business’s stock in a transaction...
Insider Selling: BioCryst Pharmaceuticals (NASDAQ:BCRX) Insider Sells $1,372,500.00 in Stock
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX – Get Free Report) insider Alane Barnes sold 150,000 shares of the stock in a transaction on...
Mark Goldsmith Sells 12,871 Shares of Revolution Medicines (NASDAQ:RVMD) Stock
Revolution Medicines, Inc. (NASDAQ:RVMD – Get Free Report) insider Mark Goldsmith sold 12,871 shares of the company’s stock in a...
BiomX (NYSEAMERICAN:PHGE) Director Sells $2,250,000.00 in Stock
BiomX Inc. (NYSEAMERICAN:PHGE – Get Free Report) Director Reuven Yeganeh sold 450,000 shares of the company’s stock in a transaction...
Gilead Sciences, Inc. $GILD Shares Sold by CIBC Private Wealth Group LLC
CIBC Private Wealth Group LLC cut its stake in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 10.3% during the 3rd quarter, according to...
Gilead Sciences, Inc. $GILD Shares Sold by CIBC Private Wealth Group LLC
CIBC Private Wealth Group LLC cut its stake in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 10.3% during the 3rd quarter, according to...